These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 23831963

  • 1. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.
    Maria NI, Brkic Z, Waris M, van Helden-Meeuwsen CG, Heezen K, van de Merwe JP, van Daele PL, Dalm VA, Drexhage HA, Versnel MA.
    Ann Rheum Dis; 2014 Jun; 73(6):1052-9. PubMed ID: 23831963
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.
    Brkic Z, Maria NI, van Helden-Meeuwsen CG, van de Merwe JP, van Daele PL, Dalm VA, Wildenberg ME, Beumer W, Drexhage HA, Versnel MA.
    Ann Rheum Dis; 2013 May; 72(5):728-35. PubMed ID: 22736090
    [Abstract] [Full Text] [Related]

  • 3. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA, Huijser E, van Helden-Meeuwsen CG, Tas L, Huizinga R, Dalm VASH, van Hagen PM, Groot N, Kamphuis S, van Daele PLA, Versnel MA.
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [Abstract] [Full Text] [Related]

  • 4. Protein and DNA methylation-based scores as surrogate markers for interferon system activation in patients with primary Sjögren's syndrome.
    Björk A, Richardsdotter Andersson E, Imgenberg-Kreuz J, Thorlacius GE, Mofors J, Syvänen AC, Kvarnström M, Nordmark G, Wahren-Herlenius M.
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958277
    [Abstract] [Full Text] [Related]

  • 5. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
    Maria NI, Steenwijk EC, IJpma AS, van Helden-Meeuwsen CG, Vogelsang P, Beumer W, Brkic Z, van Daele PL, van Hagen PM, van der Spek PJ, Drexhage HA, Versnel MA.
    Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
    [Abstract] [Full Text] [Related]

  • 6. Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes.
    Imgenberg-Kreuz J, Sandling JK, Almlöf JC, Nordlund J, Signér L, Norheim KB, Omdal R, Rönnblom L, Eloranta ML, Syvänen AC, Nordmark G.
    Ann Rheum Dis; 2016 Nov; 75(11):2029-2036. PubMed ID: 26857698
    [Abstract] [Full Text] [Related]

  • 7. Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren's syndrome.
    Huijser E, Bodewes ILA, Lourens MS, van Helden-Meeuwsen CG, van den Bosch TPP, Grashof DGB, van de Werken HJG, Lopes AP, van Roon JAG, van Daele PLA, Brkic Z, Dik WA, Versnel MA.
    Rheumatology (Oxford); 2022 Aug 03; 61(8):3491-3496. PubMed ID: 35022662
    [Abstract] [Full Text] [Related]

  • 8. Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome.
    Davies R, Sarkar I, Hammenfors D, Bergum B, Vogelsang P, Solberg SM, Gavasso S, Brun JG, Jonsson R, Appel S.
    Front Immunol; 2019 Aug 03; 10():281. PubMed ID: 30846988
    [Abstract] [Full Text] [Related]

  • 9. Systemic interferon type I and type II signatures in primary Sjögren's syndrome reveal differences in biological disease activity.
    Bodewes ILA, Al-Ali S, van Helden-Meeuwsen CG, Maria NI, Tarn J, Lendrem DW, Schreurs MWJ, Steenwijk EC, van Daele PLA, Both T, Bowman SJ, Griffiths B, Ng WF, UK Primary Sjögren’s Syndrome registry, Versnel MA.
    Rheumatology (Oxford); 2018 May 01; 57(5):921-930. PubMed ID: 29474655
    [Abstract] [Full Text] [Related]

  • 10. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
    Lopes AP, Bekker CPJ, Hillen MR, Blokland SLM, Hinrichs AC, Pandit A, Kruize AA, Radstake TRDJ, van Roon JAG.
    Front Immunol; 2021 May 01; 12():701656. PubMed ID: 34413853
    [Abstract] [Full Text] [Related]

  • 11. Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren's syndrome.
    Huijser E, Göpfert J, Brkic Z, van Helden-Meeuwsen CG, Jansen S, Mandl T, Olsson P, Schrijver B, Schreurs MWJ, van Daele PLA, Dik WA, Versnel MA.
    Rheumatology (Oxford); 2022 May 05; 61(5):2156-2166. PubMed ID: 34505866
    [Abstract] [Full Text] [Related]

  • 12. Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.
    Li Y, Lee PY, Kellner ES, Paulus M, Switanek J, Xu Y, Zhuang H, Sobel ES, Segal MS, Satoh M, Reeves WH.
    Arthritis Res Ther; 2010 May 05; 12(3):R90. PubMed ID: 20478071
    [Abstract] [Full Text] [Related]

  • 13. Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets.
    Ritter J, Szelinski F, Aue A, Stefanski AL, Rincon-Arevalo H, Chen Y, Nitschke E, Dang VD, Wiedemann A, Schrezenmeier E, Lino AC, Dörner T.
    J Autoimmun; 2024 Jul 05; 147():103243. PubMed ID: 38788537
    [Abstract] [Full Text] [Related]

  • 14. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
    Ittah M, Miceli-Richard C, Eric Gottenberg J, Lavie F, Lazure T, Ba N, Sellam J, Lepajolec C, Mariette X.
    Arthritis Res Ther; 2006 Jul 05; 8(2):R51. PubMed ID: 16507175
    [Abstract] [Full Text] [Related]

  • 15. Type I Interferon Dependent hsa-miR-145-5p Downregulation Modulates MUC1 and TLR4 Overexpression in Salivary Glands From Sjögren's Syndrome Patients.
    Jara D, Carvajal P, Castro I, Barrera MJ, Aguilera S, González S, Molina C, Hermoso M, González MJ.
    Front Immunol; 2021 Jul 05; 12():685837. PubMed ID: 34149728
    [Abstract] [Full Text] [Related]

  • 16. Increased Interferon Signaling in Vaginal Tissue of Patients With Primary Sjögren Syndrome.
    Visser A, van Nimwegen JF, Wilbrink R, Liefers SC, van der Tuuk K, Mourits MJE, Diercks GFH, Bart J, van der Vegt B, van Kempen LC, Bootsma H, Kroese FGM, Verstappen GM.
    J Rheumatol; 2024 Jul 01; 51(7):687-695. PubMed ID: 38561184
    [Abstract] [Full Text] [Related]

  • 17. Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells.
    Wildenberg ME, van Helden-Meeuwsen CG, van de Merwe JP, Drexhage HA, Versnel MA.
    Eur J Immunol; 2008 Jul 01; 38(7):2024-33. PubMed ID: 18581327
    [Abstract] [Full Text] [Related]

  • 18. Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response.
    Hamkour S, van der Heijden EH, Lopes AP, Blokland SLM, Bekker CPJ, Van Helden-Meeuwsen CG, Versnel MA, Kruize AA, Radstake TR, Leavis HL, Hillen MR, van Roon JA.
    RMD Open; 2023 Aug 01; 9(3):. PubMed ID: 37532471
    [Abstract] [Full Text] [Related]

  • 19. Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.
    Nezos A, Gravani F, Tassidou A, Kapsogeorgou EK, Voulgarelis M, Koutsilieris M, Crow MK, Mavragani CP.
    J Autoimmun; 2015 Sep 01; 63():47-58. PubMed ID: 26183766
    [Abstract] [Full Text] [Related]

  • 20. Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sjögren's syndrome.
    Wang X, Bootsma H, Terpstra J, Vissink A, van der Vegt B, Spijkervet FKL, Kroese FGM, Pringle S.
    Rheumatology (Oxford); 2020 Oct 01; 59(10):3003-3013. PubMed ID: 32159757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.